Bodybuilding Health+ vs Start Willow: Price, Shipping, Oversight Compared

Short verdict: For lower starting price and multi-program options choose Bodybuilding Health+. For faster guaranteed delivery and a direct-pay model choose Start Willow.

Start with Bodybuilding Health+

Bodybuilding Health+ vs Start Willow at a glance

This comparison of Bodybuilding Health+ vs Start Willow focuses on pricing, product mix, delivery speed, clinician oversight, and the status of compounded medications. The early verdict above is based strictly on the supplied facts.

Comparison table

1. Price and cost structure

Bodybuilding Health+ lists compounded semaglutide starting at $179 per month and tirzepatide from $209 per month with multi-month bundles that lower monthly effective cost. Start Willow lists semaglutide from $249 for the first month and $299 per month ongoing. Both platforms state no membership fees, but the supplied evidence shows Bodybuilding Health+ emphasizes lower starting prices and bundled savings while Start Willow notes a higher ongoing rate.

See Start Willow pricing

2. Delivery and convenience

Both providers operate fully online and ship medications to your door. Start Willow specifically guarantees delivery in 3 days or less from its licensed pharmacy network and highlights same day prescriptions and free 2-Day shipping in-stock. Bodybuilding Health+ confirms shipping to your door but the captured evidence does not supply a specific guaranteed delivery window.

3. Medication range and personalization

Bodybuilding Health+ positions itself as a multi-program telehealth platform offering GLP-1 (compounded semaglutide and tirzepatide), NAD+, sermorelin, and sexual performance options all on one platform. Start Willow emphasizes compounded semaglutide designed in collaboration with a Willow doctor and notes medications comparable to Ozempic and tirzepatide. In short, Bodybuilding Health+ highlights a broader program mix; Start Willow emphasizes personalized semaglutide formulation and comparisons to branded options.

Explore Bodybuilding Health+ programs

4. Clinical review and safety notes

Both providers require clinician review before prescribing. Bodybuilding Health+ states treatment is available only when a licensed clinician determines it is medically appropriate and notes medical oversight by Dr. Mark Rosenberg, M.D. Start Willow says a licensed clinician approves prescriptions and provides Willow Care Team support. Both include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.

5. Who each provider is best for

According to the supplied facts, Bodybuilding Health+ is best for adults who want GLP-1 weight management without insurance hassles and who value pricing transparency, bundled options, and a multi-program platform they can cancel anytime. Start Willow is best for patients who have experienced insurance pre-authorization difficulties and prioritize a direct-pay model with fast, guaranteed delivery.

Final comparison and closing guidance

Bodybuilding Health+ vs Start Willow comes down to tradeoffs: Bodybuilding Health+ offers lower starting prices, multi-month bundles, and a broader program set with named medical oversight. Start Willow offers a faster delivery commitment and emphasizes personalized compounded semaglutide with a direct-pay, no-insurance approach but at a higher ongoing price point. Both require clinician review and both offer compounded medications that are not FDA-approved.

Try Start Willow if fast shipping matters

Choose one if…

Choose Bodybuilding Health+ if you want lower starting pricing, multi-program options including tirzepatide from $209/mo, transparent no-membership pricing, and bundles up to 12 months with provider-reviewed oversight by Dr. Mark Rosenberg, M.D.

Choose Start Willow if you prioritize a direct-pay model that bypasses insurance hassles and a guaranteed delivery window of 3 days or less from its licensed pharmacy network, accepting the higher ongoing rate of $299/month as reported.